Sustainability in a Rapidly Evolving Landscape
Pharmaceutical and biomedical companies face external pressure to advance their sustainability performance and implement responsible sourcing strategies. While the need for change is clear, implementing sustainable practices across complex, highly regulated operations presents significant challenges. Driving alignment across functions, cascading change throughout the organization, and building a shared understanding of why sustainability matters requires a practical approach.
The Challenges Pharmaceutical & Biomedical Companies Face Today
Access to credible, science-based sustainability data is increasingly critical for pharmaceutical organizations. Without it, teams face greater compliance risk, potential supply chain disruptions, and challenges meeting investor and stakeholder expectations.
Rising Expectations from Industry Leaders
In 2023, leading pharmaceutical CEOs, through the Sustainable Markets Initiative (SMI), made sustainability expectations clear: suppliers are expected to align with ambitious environmental targets or risk falling behind.
Complex and Regulated Waste Streams
Facilities manage diverse waste streams like regulated, biohazardous, and laboratory waste which drives high disposal costs and ongoing compliance challenges.
Limited Visibility into Scope 3 Emissions
Global supply chains and contract manufacturing relationships make it difficult to accurately measure Scope 3 emissions and align suppliers with reduction goals.
Data Gaps and Fragmented Sustainability Efforts Many organizations set ambitious ESG targets but lack integrated data and coordination across waste and emissions initiatives to deliver measurable progress.
Sustainability Services for Pharma & Biomedical Companies
Sustainable Solutions Corporation partners with healthcare companies to deliver cost-effective solutions that reduce environmental impact and embed sustainability across operations. Our approach aligns with the scientific rigor and documentation standards expected in pharmaceutical and biomedical environments. Working closely with your teams, we implement practical improvements that minimize disruption and drive measurable results.
Training & Education
Consulting Services
-
A strategic roadmap that identifies opportunities for emissions reduction across operations, supply chain, and energy use to lower compliance risk and support credible progress toward targets.
-
A proven process designed to help companies reduce waste-related costs and strengthen regulatory compliance by achieving zero waste to landfill across manufacturing sites, laboratories, clinical trial facilities, and more.
-
A customized roadmap that identifies opportunities across energy, carbon, water, and waste to reduce impacts and increase profits, resulting in significant cost savings and measurable ROI.
-
A tailored program that trains sourcing and procurement teams to reduce Scope 3 emissions through supplier engagement and sustainable procurement practices.
-
A comprehensive program that trains suppliers to measure, report, and reduce their emissions, enabling them to provide accurate data and support your company’s Scope 3 goals.
-
Our Life Cycle Assessment Certified Practitioners will provide the tools and expertise to internal client teams so they can conduct life cycle assessments of various products.
Case Studies
Decarbonization Master Plan Uncovers $2.5M Annual Savings for Fortune 500 Pharma Manufacturer
SSC developed a decarbonization master plan for a Fortune 500 pharmaceutical manufacturer, aligning with company-wide SBTi targets and prioritizing Scope 1 emissions reduction.
Pharmaceutical Leader Strengthens Supplier Collaboration With SSC
Scope 3 Training Academy
SSC’s Scope 3 Training Academy drove 100% supplier engagement, improved data accuracy, and equipped suppliers to set reduction plans and science-based targets.
Pharma Supplier Achieves $1.25M in Annual Savings and Industry Recognition with Decarbonization Master Planning
A leading pharmaceutical supplier partnered with SSC to implement Decarbonization Master Planning and benchmarking, uncovering $1.25M in annual savings while creating a scalable emissions framework.
“The SSC team are highly qualified professionals in the field of sustainability. SSC has assisted Merck with achieving and, in some instances, exceeding our corporate sustainability goals.”
Connect with a Pharmaceutical & Biomedical Sustainability Expert
Our focus is delivering profit-driven solutions that reduce environmental impact. We partner with your business to solve the sustainability challenges that matter most to your teams.
Resources
Blog Posts
Pharmaceutical companies are setting firm expectations for their supply chains to reduce carbon emissions and align with net-zero targets, signaling that sustainability is no longer optional, but a critical business requirement.
As sustainability becomes a critical driver in today’s business landscape, waste minimization and zero waste to landfill are emerging as essential strategies for organizations aiming to reduce their operational costs, environmental impact, and meet carbon reduction goals
A clear understanding of Scope 3 emissions is increasingly important for organizations seeking to manage risk, improve supply chain efficiency, and stay ahead of evolving stakeholder expectations.
